Clinical Safety

Could a Heat-Activated Patch Replace Melanoma Surgery?
Research & Development Could a Heat-Activated Patch Replace Melanoma Surgery?

The diagnosis of melanoma often triggers a sequence of invasive medical procedures that prioritize immediate survival over the long-term integrity of a patient's physical appearance and comfort. As one of the most aggressive and lethal forms of skin cancer, melanoma is notorious for its rapid

Pralsetinib Significantly Extends Survival in RET Lung Cancer
Research & Development Pralsetinib Significantly Extends Survival in RET Lung Cancer

The landscape of thoracic oncology is undergoing a seismic shift as precision medicine transforms what were once considered terminal diagnoses into manageable chronic conditions for many patients. For individuals battling advanced non-small cell lung cancer (NSCLC) characterized by RET gene

Gene Therapy Shifts From Ex Vivo to In Vivo Delivery Systems
Research & Development Gene Therapy Shifts From Ex Vivo to In Vivo Delivery Systems

The landscape of modern oncology is currently witnessing a tectonic shift as clinical researchers increasingly abandon the cumbersome laboratory-based cell modification protocols that have defined the last decade. For several years, the medical community viewed Chimeric Antigen Receptor (CAR)

Ateganosine Triples Survival in Advanced Lung Cancer Trial
Research & Development Ateganosine Triples Survival in Advanced Lung Cancer Trial

The landscape of oncology is shifting as researchers uncover ways to bypass the treatment resistance that typically limits the life expectancy of patients with advanced non-small cell lung cancer. In a field where standard therapies often provide only a few months of additional survival for those

TYK2 Mechanotransduction – Review
Research & Development TYK2 Mechanotransduction – Review

Biological systems are increasingly recognized not just as chemical factories but as mechanical engines where the physical resistance of surrounding tissue determines the fate of a malignant cell. This realization has catalyzed a profound shift in oncology, moving focus from purely genetic

Sanofi Eczema Drug Faces Setbacks After Mixed Trial Results
Research & Development Sanofi Eczema Drug Faces Setbacks After Mixed Trial Results

The pharmaceutical landscape is currently witnessing a high-stakes transition as major developers scramble to identify the next generation of blockbuster treatments for atopic dermatitis. With the clock ticking on existing patents, the industry is closely monitoring whether innovative mechanisms

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later